shutterstock_1297486357_-billion-photos
Billion Photos / Shutterstock.com
1 October 2019PharmaSaman Javed

Brexit: The waiting game

As the UK’s proposed departure from the EU creeps closer, and a no-deal Brexit—leaving without an agreement as to what the future relationship between the remaining 27 members and the UK will be—looks a very real possibility, there is a growing concern across the country’s life sciences industry about how much this will impact what they do, and how much is still uncertain.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
15 July 2026   French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification patents, seeking damages from vaccines worth billions.
Pharma
14 July 2026   An enhanced agreement between the two countries cements existing protections for pharma innovators and is being hailed by the industry as a boost for investment and research.
Pharma
7 July 2026   Leading women from the pharmaceutical and biotechnology sectors are among the more than 100 professionals recognised in a newly released Influential Women in IP 2026 list, which celebrates leadership, expertise and innovation.